Client News

invIOs to present at Biotech Showcase

Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept

Spexis announces promising pre-clinical data with balixafortide in combination with various therapies on the market for treating B-cell lymphomas

Carbios hosts world’s first PET Biorecycling Summit with Bertrand Piccard, Initiator and Chairman of the Solar Impulse Foundation, as Keynote Speaker

ONWARD Reports Interim Clinical Outcomes for Implantable ARC Therapy Demonstrating Potential to Improve Blood Pressure Regulation after Spinal Cord Injury

Rentschler implements innovative learning program in collaboration with MassBioEd and WPI

Destiny Pharma: US FDA/CDC workshop highlights the need for new approaches for the prevention of hospital-acquired infections

Destiny Pharma announces finalisation of its Phase 3 development plans for XF-73 Nasal

Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study

Mainz Biomed Appoints Amy Levin as Vice President of Regulatory Affairs to Oversee Global Regulatory Strategies